Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
24 participants
OBSERVATIONAL
2023-04-29
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
GaitUp sensors (kinematic) and footscan V9 (kinetic) are the systems used for this comparison.
Nonparametric statistics are applied to verify aberrations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gait Analysis in Children With Clubfoot Treated With Tibialis Anterior Tendon Transfer
NCT03953430
Gait Analysis in Ponseti Clubfoot
NCT02022267
Gait Analysis in Idiopathic Clubfoot Patients Treated by the Ponseti Method
NCT05572411
Elastographic Assessment of Gastrocnemius Muscle Structure in Children With Idiopathic Toe Walking
NCT07163520
Neurophysiology-based Intervention of Foot Dysfunction in Sportive Children
NCT05902091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clubfeet are the most common birth defect with about 80 cases in Switzerland per year. There are two important therapies: Ponseti and manual-dynamic physiotherapy.
Ursula Issler-Wüthrich, physiotherapist, since twenty years treats exclusively clubfeet and comorbidities with clubfeet like arthrogryposis and myelomeningocele. Until today she corrected more than 400 feet with manual-dynamic physiotherapy.
Among her patients there are 11 twin pairs. In the scientific literature it is stated that in unilateral clubfoot, the other foot cannot be considered normal.With the two gait analysis systems meant for controlling the therapy results, the walking pattern of the healthy twin was compared with the pattern of the affected twin sibling.
The basis of the study is a walk over 25 meters with the GaitUp sensors (11 g) resulting in 22 quantitative digital parameters and tests on the pedobarographic plate footscan V9 leading to 10 parameters.
Statistically it will be analyzed whether there is a discrepancy between the clubfeet children and their healthy twins.
The parents in writing and the children orally gladly approved the task.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gait analysis parameters
Twins: Gait analysis
Gait analysis
Walk over 25 meters in a gym (GaitUp) Walk over 6 meters with footscan v9 in the office
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gait analysis
Walk over 25 meters in a gym (GaitUp) Walk over 6 meters with footscan v9 in the office
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr.Joller BioMedical Consulting
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Joller, PhD
Role: STUDY_DIRECTOR
Dr.Joller BioMedical Consulting
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr.Joller BioMedical Consulting
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID 2023-00290
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.